| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | -67.8% |
| Cost of Revenue | $21.0M | +0.0% |
| R&D Expense | $14.2M | -45.1% |
| SG&A Expense | $24.8M | -18.9% |
| Operating Income | -$49.7M | +10.0% |
| Net Income | -$50.1M | +19.2% |
| EPS (Basic) | -$19.19 | -57.0% |
| EPS (Diluted) | -$19.19 | -57.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | +51.9% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $1.4M | -34.4% |
| Inventory | $4.8M | +12.5% |
| Current Assets | $25.2M | +30.1% |
| Total Assets | $34.8M | +1.4% |
| Current Liabilities | $56.2M | +454.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.1M | +4.9% |
| Capital Expenditures | $192K | -43.4% |
| Investing Cash Flow | -$192K | -102.0% |
| Financing Cash Flow | $52.7M | +81.3% |
| Free Cash Flow | -$48.3M | +5.2% |
| Total Liabilities |
| $62.8M |
| -15.1% |
| Stockholders' Equity | -$28.0M | +29.3% |